Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0634745B2 - Enzymatic synthesis of N-protected peptides - Google Patents
[go: Go Back, main page]

JPH0634745B2 - Enzymatic synthesis of N-protected peptides - Google Patents

Enzymatic synthesis of N-protected peptides

Info

Publication number
JPH0634745B2
JPH0634745B2 JP10431986A JP10431986A JPH0634745B2 JP H0634745 B2 JPH0634745 B2 JP H0634745B2 JP 10431986 A JP10431986 A JP 10431986A JP 10431986 A JP10431986 A JP 10431986A JP H0634745 B2 JPH0634745 B2 JP H0634745B2
Authority
JP
Japan
Prior art keywords
water
added
mmol
layer
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP10431986A
Other languages
Japanese (ja)
Other versions
JPS62259597A (en
Inventor
裕 本多
豊人 土屋
正 竹本
利秀 湯川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP10431986A priority Critical patent/JPH0634745B2/en
Publication of JPS62259597A publication Critical patent/JPS62259597A/en
Publication of JPH0634745B2 publication Critical patent/JPH0634745B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 本発明は、N−保護ペプチドの酵素的合成法に関し、更
に詳しくは少なくとも1つのカルボキシル基をもつN−
保護ペプチドの酵素的合成法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for enzymatically synthesizing N-protected peptides, more particularly N-having at least one carboxyl group.
The present invention relates to a method for enzymatically synthesizing a protected peptide.

近年、ペプチド合成において、酵素を用いる方法がセラ
ミ化を起こさないという理由から注目を集め、種々のペ
プチド合成への利用が試みられている。ところで、この
方法では酵素として蛋白分解酵素を用いる為、通例、一
旦生成したペプチドの加水分解反応を伴う。因みに、こ
の蛋白分解酵素を用いる反応は、周知の如く、平衡反応
である。
In recent years, in peptide synthesis, attention has been paid to the fact that the method using an enzyme does not cause ceramization, and its use in various peptide synthesis has been attempted. By the way, since a proteolytic enzyme is used as an enzyme in this method, it is usually accompanied by a hydrolysis reaction of a peptide once formed. Incidentally, as is well known, the reaction using this proteolytic enzyme is an equilibrium reaction.

従って、ペプチド結合生成反応を効率よく進める為には
加水分解反応を抑制するのが重要なポイントであり、現
状では、生成物を沈殿させて反応系外に除き加水分解反
応を妨げる方法や、水と混和しない有機溶媒を水に添加
した2相系反応媒体中で反応を行ない、生成物を有機溶
媒層側に抽出して反応系外に除く方法が主として用いら
れている。しかし、これらの方法では、生成物にカルボ
キシル基を持つものなどでは、通常の酵素反応の条件の
下では水に対する溶解度が高い為、沈殿もせず、有機溶
媒層にも抽出されず、反応は効率よく進行しない。特
に、基質のアミノ基の保護基として親水性の高いホルミ
ル基(以下、Forと略記する。)やアセチル基(以下Ac
と略記する。)を用いた場合は特に顕著である。ところ
で蛋白分解酵素にはエンド型とエキソ型があるが、エキ
ソ型の酵素であるカルボキシペプチダーゼを用いた場合
には、アミノ基側の基質としてアミノ酸を使用するの
で、生成物のペプチドのカルボキシル末端は遊離のカル
ボキシル基となり、正に上記の例にあてはまる。
Therefore, it is an important point to suppress the hydrolysis reaction in order to efficiently proceed the peptide bond formation reaction, and at present, a method of precipitating the product to remove it from the reaction system to prevent the hydrolysis reaction or water A method in which a reaction is carried out in a two-phase reaction medium in which an organic solvent immiscible with is added to water and the product is extracted to the organic solvent layer side and removed from the reaction system is mainly used. However, in these methods, products having a carboxyl group in the product have high solubility in water under normal enzymatic reaction conditions, and therefore do not precipitate and are not extracted into the organic solvent layer, and the reaction is efficient. Does not progress well. In particular, a highly hydrophilic formyl group (hereinafter abbreviated as For) or an acetyl group (hereinafter Ac
Is abbreviated. ) Is particularly remarkable. By the way, there are endo-type and exo-type proteolytic enzymes.When carboxypeptidase which is an exo-type enzyme is used, an amino acid is used as a substrate on the amino group side. It becomes a free carboxyl group, which is exactly the case in the above example.

そこで本発明者らは、N−保護したアミノ酸あるいはそ
の誘導体とアミノ酸あるいはその誘導体を蛋白分解酵素
を用いて反応させ、少なくとも1つのカルボキシル基を
有するN−保護ペプチドを効率よく合成する方法につき
鋭意検討した結果、驚くべきことに、本酵素反応を有機
溶媒と水との2相系反応媒体中で4級アンモニウム塩あ
るいは4級ホスホニウム塩の存在下に行なうことによ
り、本来有機溶媒層には移行しない生成物を親油性の4
級アンモニウム塩あるいは4級ホスホニウム塩として、
有機溶媒層に移行させ、ペプチド生成反応を効率よく進
行させ得る事を見出し、本発明を完成させるに至った。
Therefore, the present inventors have earnestly studied a method for efficiently synthesizing an N-protected peptide having at least one carboxyl group by reacting an N-protected amino acid or its derivative with an amino acid or its derivative using a protease. As a result, surprisingly, by carrying out the present enzymatic reaction in a two-phase reaction medium of an organic solvent and water in the presence of a quaternary ammonium salt or a quaternary phosphonium salt, the enzyme does not originally move to the organic solvent layer. The product is lipophilic 4
As a quaternary ammonium salt or quaternary phosphonium salt,
The present invention has been completed by finding that it can be transferred to an organic solvent layer and the peptide production reaction can proceed efficiently.

本発明方法は、近年、優れた甘味剤として注目されてい
るアスパルテーム(α−L−アスパルチル−L−フェニ
ルアラニンメチルエステル)の重要な製造中間体である
N−保護−α−L−アスパルチル−L−フェニルアラニ
ン(以下、N−保護−α−APと略記する。)の合成に適
用すれば特に効力を発揮する。即ち、N−保護−α−AP
は容易にアスパルテームに変換される(特公昭60−5
0,200)が、N−保護−α−APの製法としては唯一、N
−保護−L−アスパラギン酸無水物とL−フェニルアラ
ニンを酢酸中で反応させる方法がしられている(特公昭
55−26,133)が、この方法ではN−保護−β−L−ア
スパルチル−L−フェニルアラニンが副生することや、
腐食性の高い酢酸を使用することなど、優れた方法とは
言いがたい。本発明方法を適用すれば、上記欠点を克服
し、N−保護−α−APのみを効率よく合成することがで
きる。
The method of the present invention is an important intermediate for the production of aspartame (α-L-aspartyl-L-phenylalanine methyl ester), which has been attracting attention as an excellent sweetener in recent years, and is N-protected-α-L-aspartyl-L-. It is particularly effective when applied to the synthesis of phenylalanine (hereinafter abbreviated as N-protected-α-AP). That is, N-protected-α-AP
Is easily converted to aspartame (Japanese Patent Publication No. 60-5)
0,200) is the only method for producing N-protected-α-AP,
There is a method of reacting -protected-L-aspartic anhydride and L-phenylalanine in acetic acid (JP-B-55-26,133), but in this method, N-protected-β-L-aspartyl-L-phenylalanine is used. Is a by-product,
It is difficult to say that it is an excellent method such as using highly corrosive acetic acid. By applying the method of the present invention, the above-mentioned drawbacks can be overcome and only N-protected-α-AP can be efficiently synthesized.

実施例に示すように、本発明方法を用いると、水中にお
ける酵素反応に比し、生成するN−保護ペプチドの収率
が大幅に向上する。例えば、保護基がアセチル基の場
合、水溶液中の反応では、N−アセチル−α−L−アス
パルチル−L−フェニルアラニン(以下、Ac−α−APと
略記する。)の収率は5.2%(比較例2)であるが、本
発明方法をもちいるとAc−α−APの収率は20%(実施
例7)に向上する。又、保護基がベンジルオキシカルボ
ニル基の場合も、水溶液中の反応ではN−ベンジルオキ
シカルボニル−α−L−アスパルチル−L−フェニルア
ラニンの収率は2.4%(比較例6)であるが、本発明方
法を用いると8%(実施例15)に向上した。
As shown in the examples, the use of the method of the present invention significantly improves the yield of the produced N-protected peptide as compared with the enzymatic reaction in water. For example, when the protecting group is an acetyl group, the yield of N-acetyl-α-L-aspartyl-L-phenylalanine (hereinafter abbreviated as Ac-α-AP) is 5.2% in the reaction in an aqueous solution (comparative). Example 2), the yield of Ac-α-AP is improved to 20% (Example 7) by using the method of the present invention. Even when the protecting group is a benzyloxycarbonyl group, the yield of N-benzyloxycarbonyl-α-L-aspartyl-L-phenylalanine is 2.4% (Comparative Example 6) in the reaction in an aqueous solution. The method improved to 8% (Example 15).

本発明方法によると、第1に2相系反応媒体を用いてN
−保護ペプチド合成反応を行ない、生成したN−保護ペ
プチドを親油性の4級アンモニウム塩あるいは4級ホス
ホニウム塩として有機溶媒層に移行させることによりペ
プチド生成反応を効率よく進行させ得るが、また、第2
にN−保護アミノ酸あるいはその誘導体とアミノ酸ある
いはその誘導体とを水中で蛋白分解酵素を用いて反応さ
せた後、有機溶媒と4級アンモニウム塩あるいは4級ホ
スホニウム塩を添加し、生成したN−保護ペプチドと原
料のN−保護アミノ酸あるいはその誘導体とアミノ酸あ
るいはその誘導体の有機溶媒/水の分配係数の差を利用
して生成したN−保護ペプチドを有機溶媒層に抽出する
ことも出来る。
According to the method of the present invention, firstly, N
-By carrying out a protected peptide synthesis reaction and transferring the produced N-protected peptide as a lipophilic quaternary ammonium salt or quaternary phosphonium salt to the organic solvent layer, the peptide production reaction can proceed efficiently. Two
The N-protected peptide produced by reacting an N-protected amino acid or its derivative with an amino acid or its derivative in water using a protease and then adding an organic solvent and a quaternary ammonium salt or a quaternary phosphonium salt. It is also possible to extract the N-protected peptide produced by utilizing the difference in the organic solvent / water partition coefficient between the N-protected amino acid or its derivative and the organic solvent / water derivative of the starting material into the organic solvent layer.

有機溶媒層と水層とを分離した後、第1の方法により、
水層に再度、4級アンモニウム塩あるいは4級ホスホニ
ウム塩を含む有機溶媒を加えて2層系反応媒体中でペプ
チド生成反応を行ない、これを繰返して行なえば、ペプ
チド生成反応を効率よく進行させることが出来るのはい
うまでもない。もちろん、第2の方法によってペプチド
生成反応を繰返し行なってもよい。
After separating the organic solvent layer and the aqueous layer, by the first method,
An organic solvent containing a quaternary ammonium salt or a quaternary phosphonium salt is again added to the aqueous layer to carry out a peptide formation reaction in a two-layer reaction medium, and if this is repeated, the peptide formation reaction can proceed efficiently. It goes without saying that you can do it. Of course, the peptide production reaction may be repeated by the second method.

本発明方法において用いられるN−保護−L−アスパラ
ギン酸およびその誘導体のN−保護基としては、通常の
ペプチド合成において使用される保護基、例えば、ホル
ミル基、アセチル基、ベンジルオキシカルボニル基、t
−ブチルオキシカルボニル基、フェノキシアセチル基、
1−メチル−2−アセチルビニル基及びアセトアセチル
基が用いられる他、アミノ酸残基も用いられるが、中で
もホルミル基、アセチル基、ベンジルオキシカルボニル
基が好適にもちいられる。アミノ酸残基がN−保護基と
なっているN−保護アミノ酸としては、例えば、N−ホ
ルミル−L−アラニル−L−アスパラギン酸がある。ま
た、N−保護アミノ酸誘導体としては、例えば、N−ホ
ルミル−L−アスパラギン酸−α−メチルエステルがあ
る。
As the N-protecting group of N-protected-L-aspartic acid and its derivative used in the method of the present invention, a protecting group used in usual peptide synthesis, for example, formyl group, acetyl group, benzyloxycarbonyl group, t
-Butyloxycarbonyl group, phenoxyacetyl group,
A 1-methyl-2-acetylvinyl group and an acetoacetyl group are used, and an amino acid residue is also used. Among them, a formyl group, an acetyl group and a benzyloxycarbonyl group are preferably used. Examples of N-protected amino acids in which an amino acid residue is an N-protecting group include N-formyl-L-alanyl-L-aspartic acid. Examples of N-protected amino acid derivatives include N-formyl-L-aspartic acid-α-methyl ester.

N−保護−L−アスパラギン酸またはその誘導体と反応
させるアミノ酸はL−フェニルアラニン又はその誘導体
であり、例えば、L−フェニルアラニンメチルエステル
がある。
The amino acid which is reacted with N-protected-L-aspartic acid or its derivative is L-phenylalanine or its derivative, for example L-phenylalanine methyl ester.

なお、N−保護アミノ酸またはその誘導体とそれに反応
させるアミノ酸またはその誘導体との組合せは、生成す
るN−保護ペプチドまたはその誘導体が少くとも1つの
遊離のカルボキシル基をもつものでなければならない。
これは、前述のように、生成したN−保護ペプチドまた
はその誘導体を有機溶媒に溶解している4級アンモニウ
ム塩または4級ホスホニウム塩のカチオン部分と結合さ
せて新たにN−保護ペプチドまたはその誘導体の親油性
の4級アンモニウム塩または4級ホスホニウム塩とする
ためである。
In addition, the combination of the N-protected amino acid or its derivative and the amino acid or its derivative to be reacted therewith must be such that the N-protected peptide or its derivative produced has at least one free carboxyl group.
As described above, the N-protected peptide or its derivative is newly bonded by binding the produced N-protected peptide or its derivative with the cation portion of the quaternary ammonium salt or quaternary phosphonium salt dissolved in an organic solvent. This is because it is a lipophilic quaternary ammonium salt or quaternary phosphonium salt.

又、有機溶媒としては、4級アンモニウム塩または4級
ホスホニウム塩を溶解し得てかつ水と均一に混和しない
もので出発物質及び目的生成物に特に活性なものでなけ
れば、いかなる溶媒も使用することが出来る。トルエ
ン、キシレン、ヘキサンのごとき炭化水素類、酢酸エチ
ル、酢酸ブチルのごときエステル類、クロロホルム、四
塩化炭素、エチレンジクロライドのごときハロゲン化炭
化水素類、ブタノール、アミルアルコールのごときアル
コール類、メチルエチルケトンのごときケトン類、ジエ
チルエーテル、ジイソプロピルエーテルのごときエーテ
ル類などが代表的なものであり、これらのうちの任意の
2種類以上からなる混合溶媒を使用することも出来る。
As the organic solvent, any solvent can be used as long as it can dissolve the quaternary ammonium salt or the quaternary phosphonium salt and is not uniformly miscible with water and is not particularly active in the starting material and the intended product. You can Hydrocarbons such as toluene, xylene and hexane, esters such as ethyl acetate and butyl acetate, halogenated hydrocarbons such as chloroform, carbon tetrachloride and ethylene dichloride, alcohols such as butanol and amyl alcohol, and ketones such as methyl ethyl ketone. Typical examples thereof include ethers such as diethyl ether and diisopropyl ether, and a mixed solvent composed of any two or more of these may be used.

本発明の方法においてもちいられる酵素としては蛋白分
解酵素であれば特に制限はない。又、酵素反応を行なう
際の反応液のpHは使用する酵素の種類により異なり、例
えば、プロテアーゼM(天野製薬社製)及びオリエンタ
ーゼ5A(オリエンタル酵母社製)の場合は3〜7で、
サモアーゼ(大和化成社製)の場合は6〜8である。本
発明の酵素反応は温度10〜90℃、酵素活性を維持す
る観点からは20〜50℃で行なうとよい。
The enzyme used in the method of the present invention is not particularly limited as long as it is a protease. Further, the pH of the reaction solution when carrying out the enzyme reaction varies depending on the type of the enzyme used, and is 3 to 7 in the case of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) and Orientase 5A (manufactured by Oriental Yeast Co., Ltd.),
In the case of Samoaze (manufactured by Daiwa Kasei Co., Ltd.), it is 6 to 8. The enzymatic reaction of the present invention is preferably carried out at a temperature of 10 to 90 ° C, and 20 to 50 ° C from the viewpoint of maintaining the enzymatic activity.

本発明の方法において、両出発物質の使用濃度には特に
制限はないが、ペプチド生成反応をより効率よく進行さ
せるためには、高い方が望ましい。ペプチド生成反応を
進行させるという観点からは、出発物質の濃度が重要で
あって、両者の使用比率には特に制限はない。
In the method of the present invention, the concentrations of both starting materials used are not particularly limited, but are preferably higher in order to allow the peptide-forming reaction to proceed more efficiently. From the viewpoint of promoting the peptide-forming reaction, the concentration of the starting material is important, and the ratio of use of both is not particularly limited.

本発明方法において用いられる4級アンモニウム塩ある
いはホスホニウム塩としては特に制限はなく、トリオク
チルメチルアンモニウムクロリド(ヘンケル社製Aliqua
t336など),セチルジメチルベンジルアンモニウム
クロリド、テトラn−ブチルホスホニウムブロマイドな
どが好適にもちいられる。又、その量は両出発物質に対
して多ければ多い程、目的生成物を有機溶媒層に移行さ
せ得るが、あまり多すぎると酵素活性を低下させる場合
があるので、両出発物質の総量に対して0.5〜5.0重量倍
の比率でもちいられる。
The quaternary ammonium salt or phosphonium salt used in the method of the present invention is not particularly limited, and trioctylmethylammonium chloride (Aliqua manufactured by Henkel) is used.
t336), cetyl dimethyl benzyl ammonium chloride, tetra n-butyl phosphonium bromide and the like are preferably used. Also, the larger the amount of both starting materials, the more the target product can be transferred to the organic solvent layer, but if it is too large, the enzyme activity may be reduced. It can be used in a ratio of 0.5 to 5.0 times by weight.

有機溶媒層に第4級アンモニウム塩またはホスホニウム
塩の形で移行したN−保護ペプチドまたはその誘導体を
分離回収するには、例えば、次のようにするとよい。4
級アンニウム塩またはホスホニウム塩の形になったN−
保護ペプチドまたはその誘導体は例えば食塩水等と混合
することにより遊離させることができる。すなわち、分
離した有機溶媒層から食塩水で抽出すればよい。食塩水
の濃度は2〜20(重量)%がよい。
In order to separate and collect the N-protected peptide or its derivative transferred to the organic solvent layer in the form of a quaternary ammonium salt or a phosphonium salt, for example, the following may be performed. Four
N- in the form of a primary annium salt or phosphonium salt
The protected peptide or its derivative can be released by mixing with, for example, saline. That is, the separated organic solvent layer may be extracted with saline. The concentration of saline is preferably 2 to 20 (weight)%.

以下、実施例、比較例により、本発明をさらに説明す
る。
Hereinafter, the present invention will be further described with reference to Examples and Comparative Examples.

実施例1 N−アセチル−L−アスパラギン酸(以下、Ac-Aspと略
記する。)0.54g(3.1mmol)とL−フェニルアラニン
(以下、Pheと略記する。)0.1g(0.6mmol)を適量の
水に溶解し、水酸化ナトリウム水溶液を加えてpH4.5に
調整した後、全体を5mlにした。この水溶液にプロテア
ーゼM(天野製薬社製)50mgを添加した。完全に溶解
させた後、トリオクチルメチルアンモニウムクロリド
(Aliquat336)1.25g(3.1mmol)のトルエン溶液1
0mlを加え、40℃で24時間振盪した。
Example 1 0.54 g (3.1 mmol) of N-acetyl-L-aspartic acid (hereinafter abbreviated as Ac-Asp) and 0.1 g (0.6 mmol) of L-phenylalanine (hereinafter abbreviated as Phe) in appropriate amounts. After dissolving in water and adding sodium hydroxide aqueous solution to adjust the pH to 4.5, the total volume was adjusted to 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolved, 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) in toluene solution 1
0 ml was added, and the mixture was shaken at 40 ° C. for 24 hours.

反応液中(水層及びトルエン層)のAc−α−APを高速液
体クロマトグラフィー(以下、HPLCと略記する。)にて
定量したところ、Pheに対して4.2%の収率で生成してい
た(水層1.2%,トルエン層3.0%)。
When Ac-α-AP in the reaction solution (aqueous layer and toluene layer) was quantified by high performance liquid chromatography (hereinafter abbreviated as HPLC), it was produced in a yield of 4.2% with respect to Phe. (Water layer 1.2%, toluene layer 3.0%).

実施例2 Ac-Asp0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、トリオクチルメチルアンモニウムクロリ
ド(Aliquat336)1.25g(3.1mmol)の四塩化炭素溶
液10mlを加え、40℃で24時間振盪した。
Example 2 Ac-Asp (0.54 g, 3.1 mmol) and Phe (0.1 g, 0.6 mmol) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 10 ml of a carbon tetrachloride solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) was added, and the mixture was shaken at 40 ° C. for 24 hours.

反応液中(水層及び四塩化炭素層)のAc−α−APを、HP
LCにて定量したところ、Pheに対して4.3%の収率で生成
していた(水層1.1%,四塩化炭素層3.2%)。
Ac-α-AP in the reaction solution (water layer and carbon tetrachloride layer)
When quantified by LC, it was found to be produced in a yield of 4.3% based on Phe (water layer 1.1%, carbon tetrachloride layer 3.2%).

実施例3 Ac-Asp 0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、セチルジメチルベンジルアンモニウムク
ロリド1.23g(3.1mmol)のクロロホルム溶液10mlを
加え、40℃で24時間振盪した。
Example 3 Ac-Asp (0.54 g, 3.1 mmol) and Phe (0.1 g, 0.6 mmol) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 10 ml of a chloroform solution containing 1.23 g (3.1 mmol) of cetyldimethylbenzylammonium chloride was added, and the mixture was shaken at 40 ° C. for 24 hours.

反応液中(水層及びクロロホルム層)のAc−α−APを、
HPLCにて定量したところ、Pheに対して4.2%の収率で生
成していた(水層1.2%,クロロホルム層3.0%)。
Ac-α-AP in the reaction solution (water layer and chloroform layer),
When quantified by HPLC, it was produced in a yield of 4.2% based on Phe (water layer 1.2%, chloroform layer 3.0%).

実施例4 Ac-Asp 0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、テトラn−ブチルホスホニウムブロマイ
ド1.05g(3.1mmol)の1,2−ジクロルエタン溶液1
0mlを加え、40℃で24時間振盪した。
Example 4 Ac-Asp (0.54 g, 3.1 mmol) and Phe (0.1 g, 0.6 mmol) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After being completely dissolved, a solution of tetra-n-butylphosphonium bromide 1.05 g (3.1 mmol) in 1,2-dichloroethane 1
0 ml was added, and the mixture was shaken at 40 ° C. for 24 hours.

反応液中(水層及び1,2−ジクロルエタン層)のAc−
α−APを、HPLCにて定量したところ、Pheに対して3.1%
の収率で生成していた(水層1.6%,1,2−ジクロル
エタン層1.5%)。
Ac- in the reaction solution (water layer and 1,2-dichloroethane layer)
When α-AP was quantified by HPLC, it was 3.1% with respect to Phe.
Was produced in a yield of (water layer 1.6%, 1,2-dichloroethane layer 1.5%).

比較例1(実施例1〜5に対する比較例) Ac-Asp 0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、40℃で24時間振盪した。
Comparative Example 1 (Comparative Example for Examples 1 to 5) 0.54 g (3.1 mmol) of Ac-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, the mixture was shaken at 40 ° C. for 24 hours.

水液中のAc−α−APをHPLCにて定量したところ、Pheに
対して1.6%の収率で生成していた。
When Ac-α-AP in the aqueous solution was quantified by HPLC, it was produced in a yield of 1.6% based on Phe.

実施例5 Ac-Asp 2.17g(12.4mmol)とPhe 0.1g(0.6mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
4.5に調整した後、全体を5mlにした。この水溶液にプ
ロテアーゼM(天野製薬社製)50mgを添加した。完全
に溶解させた後、トリオクチルメチルアンモニウムクロ
リド(Aliquat336)1.25g(3.1mmol)のトルエン溶
液10mlを加え、40℃で44時間振盪した。
Example 5 2.17 g (12.4 mmol) of Ac-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 4.5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 10 ml of a toluene solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) was added, and the mixture was shaken at 40 ° C. for 44 hours.

反応液中(水層及びトルエン層)のAc−α−APを、HPLC
にて定量したところ、Pheに対して11.1%の収率で生成
していた(水層3.3%,トルエン層7.8%)。
Ac-α-AP in the reaction solution (water layer and toluene layer) was analyzed by HPLC.
The yield was 11.1% based on Phe (water layer 3.3%, toluene layer 7.8%).

実施例6 Ac-Asp 2.17g(12.4mmol)とPhe 0.1g(0.6mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
4.5に調整した後、全体を5mlにした。この水溶液にプ
ロテアーゼM(天野製薬社製)50mgを添加した。完全
に溶解させた後、トリオクチルメチルアンモニウムクロ
リド(Aliquat336)1.25g(3.1mmol)のトルエン/
ヘキサン(1/1)溶液10mlを加え、40℃で44時
間振盪した。
Example 6 2.17 g (12.4 mmol) of Ac-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 4.5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After complete dissolution, 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) in toluene /
10 ml of a hexane (1/1) solution was added, and the mixture was shaken at 40 ° C. for 44 hours.

反応液中(水層及びトルエン/ヘキサン層)のAc−α−
APを、HPLCにて定量したところ、Pheに対して11.0%の
収率で生成していた(水層3.1%,トルエン/ヘキサン
層7.9%)。
Ac-α- in the reaction solution (water layer and toluene / hexane layer)
When AP was quantified by HPLC, it was found to be produced in a yield of 11.0% with respect to Phe (water layer 3.1%, toluene / hexane layer 7.9%).

実施例7 Ac-Asp 2.17g(12.4mmol)とPhe 0.1g(0.6mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
4.5に調整した後、全体を5mlにした。この水溶液にプ
ロテアーゼM(天野製薬社製)50mgを添加した。完全
に溶解させた後、セチルジメチルベンジルアンモニウム
クロリド2.46g(6.2mmol)のクロロホルム溶液20ml
を加え、40℃で44時間振盪した。
Example 7 2.17 g (12.4 mmol) of Ac-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 4.5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 20 ml of a chloroform solution of 2.46 g (6.2 mmol) of cetyldimethylbenzylammonium chloride
Was added and shaken at 40 ° C. for 44 hours.

反応液中(水層及びクロロホルム層)のAc−α−APを、
HPLCにて定量したところ、Pheに対して20.1%の収率で
生成していた(水層5.1%,クロロホルム層15.0%)。
Ac-α-AP in the reaction solution (water layer and chloroform layer),
When quantified by HPLC, it was found to be produced in a yield of 20.1% with respect to Phe (water layer 5.1%, chloroform layer 15.0%).

比較例2(実施例5〜7に対する比較例) Ac-Asp 2.17g(12.4mmol)とPhe 0.1g(0.6mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
4.5に調整した後、全体を5mlにした。この水溶液にプ
ロテアーゼM(天野製薬社製)50mgを添加した。完全
に溶解させた後、40℃で44時間振盪した。
Comparative Example 2 (Comparative Example to Examples 5 to 7) 2.17 g (12.4 mmol) of Ac-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 4.5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, the mixture was shaken at 40 ° C. for 44 hours.

水液中のAc−α−APをHPLCにて定量したところ、Pheに
対して5.2%の収率で生成していた。
When Ac-α-AP in the water solution was quantified by HPLC, it was produced in a yield of 5.2% based on Phe.

実施例8 Ac-Asp 0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)200mgを添加した。完全
に溶解させた後、トリオクチルメチルアンモニウムクロ
リド(Aliquat336)1.25g(3.1mmol)のトルエン溶
液10mlを加え、40℃で48時間振盪した。
Example 8 Ac-Asp (0.54 g, 3.1 mmol) and Phe (0.1 g, 0.6 mmol) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution, 200 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.) was added. After completely dissolving, 10 ml of a toluene solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat336) was added, and the mixture was shaken at 40 ° C. for 48 hours.

反応液中(水層及びトルエン層)のAc−α−APを、HPLC
にて定量したところ、Pheに対して5.0%の収率で生成し
ていた(水層1.5%,トルエン層3.5%)。
Ac-α-AP in the reaction solution (water layer and toluene layer) was analyzed by HPLC.
The yield was 5.0% based on Phe (water layer 1.5%, toluene layer 3.5%).

実施例9 Ac-Asp 0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH3.
0に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、トリオクチルメチルアンモニウムクロリ
ド(Aliquat336)1.25g(3.1mmol)のトルエン溶液
10mlを加え、40℃で22時間振盪した。
Example 9 0.54 g (3.1 mmol) of Ac-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 3.
After adjusting to 0, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 10 ml of a toluene solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat336) was added, and the mixture was shaken at 40 ° C. for 22 hours.

反応液中(水層及びトルエン層)のAc−α−APを、HPLC
にて定量したところ、Pheに対して3.4%の収率で生成し
ていた(水層0.9%,トルエン層25%)。
Ac-α-AP in the reaction solution (water layer and toluene layer) was analyzed by HPLC.
The yield was 3.4% based on Phe (water layer 0.9%, toluene layer 25%).

実施例10 Ac-Asp 0.54g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、トリオクチルメチルアンモニウムクロリ
ド(Aliquat336)1.25g(3.1mmol)のトルエン溶液
10mlを加え、25℃で96時間振盪した。
Example 10 Ac-Asp (0.54 g, 3.1 mmol) and Phe (0.1 g, 0.6 mmol) were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 10 ml of a toluene solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat336) was added, and the mixture was shaken at 25 ° C. for 96 hours.

反応液中(水層及びトルエン層)のAc−α−APを、HPLC
にて定量したところ、Pheに対して4.0%の収率で生成し
ていた(水層1.2%,トルエン層2.8%)。
Ac-α-AP in the reaction solution (water layer and toluene layer) was analyzed by HPLC.
The yield was 4.0% based on Phe (water layer 1.2%, toluene layer 2.8%).

実施例11 N−ホルミル−L−アスパラギン酸(以下、For-Aspと
略記する。)0.5g(3.1mmol)とPhe 0.1g(0.6mmol)
を適量の水に溶解し、水酸化ナトリウム水溶液を加えて
pH4.5に調整した後、全体を5mlにした。この水溶液に
プロテアーゼM(天野製薬社製)50mgを添加した。完
全に溶解された後、トリオクチルメチルアンモニウムク
ロリド(Aliquat336)1.25g(3.1mmol)のトルエン
溶液10mlを加え、40℃で72時間振盪した。
Example 11 N-formyl-L-aspartic acid (hereinafter abbreviated as For-Asp) 0.5 g (3.1 mmol) and Phe 0.1 g (0.6 mmol)
Is dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution is added.
After adjusting to pH 4.5, the whole was brought to 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolved, 10 ml of a toluene solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) was added, and the mixture was shaken at 40 ° C. for 72 hours.

反応液中(水層及びトルエン層)のN−ホルミル−α−
L−アスパルチル−L−フェニルアラニン(以下、For
−α−APと略記する。)をHPLCにて定量したところ、Ph
eに対して2.9%の収率で生成していた(水層0.7%,ト
ルエン層2.2%)。
N-formyl-α-in the reaction liquid (water layer and toluene layer)
L-aspartyl-L-phenylalanine (hereinafter, For
Abbreviated as -α-AP. ) Was determined by HPLC.
The yield was 2.9% based on e (water layer 0.7%, toluene layer 2.2%).

比較例3(実施例11に対する比較例) For-Asp 0.5g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にプロ
テアーゼM(天野製薬社製)50mgを添加した。完全に
溶解させた後、40℃で72時間振盪した。
Comparative Example 3 (Comparative Example to Example 11) 0.5 g (3.1 mmol) of For-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, the mixture was shaken at 40 ° C. for 72 hours.

水液中のFor−α−APをHPLCにて定量したところ、Pheに
対して0.8%の収率で生成していた。
When For-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced in a yield of 0.8% with respect to Phe.

実施例12 For-Asp 2.0g(12.4mmol)とPhe 0.1g(0.6mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
4.5に調整した後、全体を5mlにした。この水溶液にプ
ロテアーゼM(天野製薬社製)50mgを添加した。完全
に溶解させた後、トリオクチルメチルアンモニウムクロ
リド(Aliquat336)1.25g(3.1mmol)のトルエン溶
液10mlを加え、40℃で76時間振盪した。
Example 12 2.0 g (12.4 mmol) of For-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 4.5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, 10 ml of a toluene solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat336) was added, and the mixture was shaken at 40 ° C. for 76 hours.

反応液中(水層及びトルエン層)のFor−α−APをHPLC
にて定量したところ、Pheに対して6.3%の収率で生成し
ていた(水層2.0%,トルエン層4.3%)。
HPLC of For-α-AP in the reaction solution (water layer and toluene layer)
The yield was 6.3% based on Phe (water layer 2.0%, toluene layer 4.3%).

実施例13 For-Asp 0.5g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にオリ
エンターゼ5A(オリエンタル酵母社製)50mgを添加
した。完全に溶解させた後、トリオクチルメチルアンモ
ニウムクロリド(Aliquat336)1.25g(3.1mmol)の
酢酸エチル溶液10mlを加え、40℃で71時間振盪し
た。
Example 13 For-Asp 0.5 g (3.1 mmol) and Phe 0.1 g (0.6 mmol) were dissolved in an appropriate amount of water, and a sodium hydroxide aqueous solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution, 50 mg of Orientase 5A (manufactured by Oriental Yeast Co., Ltd.) was added. After completely dissolving, 10 ml of an ethyl acetate solution containing 1.25 g (3.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) was added, and the mixture was shaken at 40 ° C. for 71 hours.

反応液中(水層及び酢酸エチル層)のFor−α−APをHPL
Cにて定量したところ、Pheに対して1.1%の収率で生成
していた(水層0.3%,酢酸エチル層0.8%)。
HPL of For-α-AP in the reaction solution (water layer and ethyl acetate layer)
When quantified with C, the yield was 1.1% based on Phe (water layer 0.3%, ethyl acetate layer 0.8%).

比較例4(実施例13に対する比較例) For-Asp 0.5g(3.1mmol)とPhe 0.1g(0.6mmol)を適
量の水に溶解し、水酸化ナトリウム水溶液を加えてpH4.
5に調整した後、全体を5mlにした。この水溶液にオリ
エンターゼ5A(オリエンタル酵母社製)50mgを添加
した。完全に溶解させた後、40℃で71時間振盪し
た。
Comparative Example 4 (Comparative Example to Example 13) For-Asp 0.5 g (3.1 mmol) and Phe 0.1 g (0.6 mmol) were dissolved in an appropriate amount of water, and a sodium hydroxide aqueous solution was added to adjust the pH to 4.
After adjusting to 5, the total volume was 5 ml. To this aqueous solution, 50 mg of Orientase 5A (manufactured by Oriental Yeast Co., Ltd.) was added. After completely dissolving, the mixture was shaken at 40 ° C. for 71 hours.

水液中のFor−α−APをHPLCにて定量したところ、Pheに
対して0.4%の収率で生成していた。
When For-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced in a yield of 0.4% based on Phe.

実施例14 N−ホルミル−L−アスパラギン酸−α−メチルエステ
ル(以下、For-Asp-OMeと略記する。)0.54g(3.1mmo
l)とPhe 0.1g(0.6mmol)を適量の水に溶解し、水酸
化ナトリウム水溶液を加えてpH4.5に調整した後、全体
を5mlにした。この水溶液にプロテアーゼM(天野製薬
社製)50mgを添加した。完全に溶解させた後、トリオ
クチルメチルアンモニウムクロリド(Aliquat336)
1.25g(3.1mmol)のトルエン溶液10mlを加え、40
℃で65時間振盪した。
Example 14 0.54 g (3.1 mmo) of N-formyl-L-aspartic acid-α-methyl ester (hereinafter abbreviated as For-Asp-OMe)
l) and Phe 0.1 g (0.6 mmol) were dissolved in an appropriate amount of water, and a sodium hydroxide aqueous solution was added to adjust the pH to 4.5, and then the whole was adjusted to 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After complete dissolution, trioctylmethyl ammonium chloride (Aliquat 336)
Add 10 ml of a 1.25 g (3.1 mmol) toluene solution, and add 40
Shake at 65 ° C. for 65 hours.

反応液中(水層及びトルエン層)のFor−α−APをHPLC
にて定量したところ、Pheに対して7.2%の収率で生成し
ていた(水層1.9%,トルエン層5.3%)。
HPLC of For-α-AP in the reaction solution (water layer and toluene layer)
The yield was 7.2% based on Phe (water layer 1.9%, toluene layer 5.3%).

比較例5(実施例14に対する比較例) For-Asp-OMe 0.54g(3.1mmol)とPhe 0.1g(0.6mmo
l)を適量の水に溶解し、水酸化ナトリウム水溶液を加
えてpH4.5に調整した後、全体を5mlにした。この水溶
液にプロテアーゼM(天野製薬社製)50mgを添加し
た。完全に溶解させた後、40℃で65時間振盪した。
Comparative Example 5 (Comparative Example to Example 14) For-Asp-OMe 0.54 g (3.1 mmol) and Phe 0.1 g (0.6 mmo
l) was dissolved in an appropriate amount of water, an aqueous sodium hydroxide solution was added to adjust the pH to 4.5, and then the whole was adjusted to 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, the mixture was shaken at 40 ° C. for 65 hours.

水液中のFor−α−APをHPLCにて定量したところ、Pheに
対して2.1%の収率で生成していた。
When For-α-AP in the aqueous solution was quantified by HPLC, it was found to be produced in a yield of 2.1% based on Phe.

実施例15 N−ベンジルオキシカルボニル−L−アスパラギン酸
(以下、Z−Aspと略記する。)0.83g(3.1mmol)とPh
e 0.1g(0.6mmol)を適量の水に溶解し、水酸化ナトリ
ウム水溶液を加えてpH4.5に調整した後、全体を5mlに
した。この水溶液にプロテアーゼM(天野製薬社製)5
0mgを添加した。完全に溶解させた後、トリオクチルメ
チルアンモニウムクロリド(Aliquat336)1.25g
(3.1mmol)のトルエン溶液10mlを加え、40℃で4
4時間振盪した。
Example 15 N-benzyloxycarbonyl-L-aspartic acid (hereinafter abbreviated as Z-Asp) 0.83 g (3.1 mmol) and Ph
0.1 g (0.6 mmol) of e was dissolved in an appropriate amount of water, an aqueous sodium hydroxide solution was added to adjust the pH to 4.5, and then the whole was adjusted to 5 ml. Protease M (Amano Pharmaceutical Co., Ltd.) 5
0 mg was added. After completely dissolving, 1.25 g of trioctylmethyl ammonium chloride (Aliquat 336)
Add 10 ml of a toluene solution of (3.1 mmol), and add 4 at 40 ° C.
Shake for 4 hours.

反応液中(水層及びトルエン層)のN−ベンジルオキシ
カルボニル−α−L−アスパルチル−L−フェニルアラ
ニン(以下、Z−α−APと略記する。)をHPLCにて定量
したところ、Pheに対して8.1%の収率で生成していた
(水層1.1%,トルエン層7.0%)。
N-benzyloxycarbonyl-α-L-aspartyl-L-phenylalanine (hereinafter abbreviated as Z-α-AP) in the reaction solution (water layer and toluene layer) was quantified by HPLC, and it was determined to be Phe. Was produced in a yield of 8.1% (water layer 1.1%, toluene layer 7.0%).

比較例6(実施例15に対する比較例) Z−Asp 0.83g(3.1mmol)とPhe 0.1g(0.6mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
4.5に調整した後、全体を5mlにした。この水溶液にプ
ロテアーゼM(天野製薬社製)50mgを添加した。完全
に溶解させた後、40℃で44時間振盪した。
Comparative Example 6 (Comparative Example to Example 15) 0.83 g (3.1 mmol) of Z-Asp and 0.1 g (0.6 mmol) of Phe were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 4.5, the total volume was 5 ml. To this aqueous solution was added 50 mg of Protease M (manufactured by Amano Pharmaceutical Co., Ltd.). After completely dissolving, the mixture was shaken at 40 ° C. for 44 hours.

水液中のZ−α−APをHPLCにて定量したところ、Pheに
対して2.4%の収率で生成していた。
When Z-α-AP in the aqueous solution was quantified by HPLC, it was produced in a yield of 2.4% based on Phe.

実施例16 Z−Asp 0.67g(2.5mmol)とL−フェニルアラニンメ
チルエステル(以下、PMと略記する。)0.45g(2.5m
mol)を適量の水に溶解し、水酸化ナトリウム水溶液を
加えてpH6.2に調整した後、全体を18mlにした。この
水溶液にサモアーゼ(大和化成社製)120mgを添加し
た。完全に溶解させた後、トリオクチルメチルアンモニ
ウムクロリド(Aliquat336)2.06g(5.1mmol)のト
ルエン溶液20mlを加え、40℃で3時間振盪した。
Example 16 Z-Asp 0.67 g (2.5 mmol) and L-phenylalanine methyl ester (hereinafter abbreviated as PM) 0.45 g (2.5 m)
(mol) was dissolved in an appropriate amount of water, sodium hydroxide aqueous solution was added to adjust the pH to 6.2, and then the whole was adjusted to 18 ml. To this aqueous solution, 120 mg of Samoases (manufactured by Daiwa Kasei Co., Ltd.) was added. After completely dissolving, 20 ml of a toluene solution containing 2.06 g (5.1 mmol) of trioctylmethylammonium chloride (Aliquat 336) was added, and the mixture was shaken at 40 ° C. for 3 hours.

反応液中(水層及びトルエン層)のN−ベンジルオキシ
カルボニル−α−L−フェニルアラニンメチルエステル
(以下、Z−α−APMと略記する。)をHPLCにて定量し
たところ、Pheに対して54.6%の収率で生成していた
(水層18.0%,トルエン層36.6%)。
N-benzyloxycarbonyl-α-L-phenylalanine methyl ester (hereinafter abbreviated as Z-α-APM) in the reaction solution (water layer and toluene layer) was quantified by HPLC, and it was 54.6 relative to Phe. % (Water layer 18.0%, toluene layer 36.6%).

比較例7(実施例16に対する比較例) Z−Asp 0.67g(2.5mmol)とPM0.45g(2.5mmol)を
適量の水に溶解し、水酸化ナトリウム水溶液を加えてpH
6.2に調整した後、全体を18mlにした。この水溶液に
サモアーゼ(大和化成社製)120mgを添加した。完全
に溶解させた後、40℃で3時間振盪した。
Comparative Example 7 (Comparative Example to Example 16) 0.67 g (2.5 mmol) of Z-Asp and 0.45 g (2.5 mmol) of PM were dissolved in an appropriate amount of water, and an aqueous sodium hydroxide solution was added to adjust the pH.
After adjusting to 6.2, the total volume was 18 ml. To this aqueous solution, 120 mg of Samoases (manufactured by Daiwa Kasei Co., Ltd.) was added. After completely dissolving, the mixture was shaken at 40 ° C. for 3 hours.

水液中のZ−α−APMをHPLCにて定量したところ、Pheに
対して19.4%の収率で生成していた。
When Z-α-APM in the aqueous solution was quantified by HPLC, it was found to be produced in a yield of 19.4% with respect to Phe.

実施例17 比較例3と同様に反応させて得られたFor-Asp 2.5g,F
or−α−AP 0.009g及びL−Phe 0.5gを含む酵素反応
液25mlにトリオクチルメチルアンモニウムクロリド6.
25gのトルエン溶液50mlを加え、pHを6.0に調整した
後、37℃で15分間振盪した。
Example 17 For-Asp 2.5 g, F obtained by reacting in the same manner as in Comparative Example 3
Trioctylmethylammonium chloride 6. was added to 25 ml of an enzyme reaction solution containing 0.009 g of or-α-AP and 0.5 g of L-Phe.
After adding 50 g of 25 g toluene solution to adjust the pH to 6.0, the mixture was shaken at 37 ° C. for 15 minutes.

トルエン層を分離し、For-Asp,For−α−AP及びL−Phe
をHPLCにて定量したところ、トルエン層中にFor−α−A
Pは76%抽出されていた。一方、For-Asp,Pheは、それ
ぞれ、9%,7%抽出されたにすぎなかった。因みに、
For−α−AP,For-Asp及びPheの水−トルエン間の分配係
数は、それぞれ、1.35,0.04,0.03であった。
The toluene layer is separated, and For-Asp, For-α-AP and L-Phe are separated.
Was quantified by HPLC. As a result, For-α-A was found in the toluene layer.
76% of P was extracted. On the other hand, For-Asp and Phe were only extracted by 9% and 7%, respectively. By the way,
The water-toluene distribution coefficients of For-α-AP, For-Asp and Phe were 1.35, 0.04 and 0.03, respectively.

比較例8(実施例17に対する比較例) トリオクチルメチルアンモニウムクロリドを添加しない
以外は、実施例18と同様の実験を行なったところ、Fo
r−α−APはトルエン層中に全く抽出されず、その分配
係数は0であった。
Comparative Example 8 (Comparative Example to Example 17) The same experiment as in Example 18 was conducted except that trioctylmethylammonium chloride was not added.
No r-α-AP was extracted into the toluene layer, and its partition coefficient was 0.

実施例18 比較例1と同様に反応して得られたAc-Asp 2.6g,Ac−
α−AP 0.015g及びPhe 0.5gを含む酵素反応液25ml
にトリオクチルメチルアンモニウムクロリド6.25gのト
ルエン溶液50mlを加え、pHを4.4に調整した後、37
℃で15分間振盪した。
Example 18 Ac-Asp 2.6 g, Ac-obtained by the same reaction as in Comparative Example 1
25 ml of enzyme reaction solution containing 0.015 g of α-AP and 0.5 g of Phe
50 ml of a toluene solution of 6.25 g of trioctylmethylammonium chloride was added to the mixture to adjust the pH to 4.4, and then 37
Shake at 15 ° C for 15 minutes.

トルエン層を分離し、Ac-Asp,Ac−α−AP及びL−Pheを
HPLCにて定量したところ、トルエン層中にAc−α−APは
63%抽出されていた。一方、Ac-Asp,Pheは、それぞ
れ、9%,2%抽出されたにすぎなかった。因みに、Ac
−α−AP,Ac-Asp及びL−Pheの水−トルエン間の分配係
数は、それぞれ、1.03,0.07,0.01であった。
The toluene layer was separated, and Ac-Asp, Ac-α-AP and L-Phe were separated.
As a result of quantification by HPLC, 63% of Ac-α-AP was extracted in the toluene layer. On the other hand, Ac-Asp and Phe were only extracted by 9% and 2%, respectively. By the way, Ac
The distribution coefficients of -α-AP, Ac-Asp and L-Phe between water and toluene were 1.03, 0.07 and 0.01, respectively.

比較例9(実施例18に対する比較例) トリオクチルメチルアンモニウムクロリドを添加しない
以外は、実施例19と同様の実験を行なったところ、Ac
−α−APはトルエン層中に全く抽出されず、その分配係
数は0であった。
Comparative Example 9 (Comparative Example to Example 18) The same experiment as in Example 19 was carried out except that trioctylmethylammonium chloride was not added.
-Α-AP was not extracted in the toluene layer at all, and its partition coefficient was 0.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】N−保護−L−アスパラギン酸またはその
誘導体とL−フェニルアラニンまたはその誘導体とを、
4級アンモニウム塩または4級ホスホニウム塩を溶解し
た水非混和性有機溶媒と水との2相系反応媒体中におい
て水層で蛋白分解酵素を用いて反応させ、生成したN−
保護−α−L−アスパルチル−L−フェニルアラニンま
たはその誘導体を親油性の4級アンモニウム塩または4
級ホスホニウム塩として有機溶媒相に移行させることを
特徴とするN−保護−α−L−アスパルチル−L−フェ
ニルアラニンまたはその誘導体の酵素的合成法。
1. N-protected-L-aspartic acid or a derivative thereof and L-phenylalanine or a derivative thereof,
N- produced by reacting with a protease in a water layer in a two-phase reaction medium of a water-immiscible organic solvent in which a quaternary ammonium salt or a quaternary phosphonium salt is dissolved and water
Protecting -α-L-aspartyl-L-phenylalanine or its derivative with a lipophilic quaternary ammonium salt or 4
A method for enzymatically synthesizing N-protected-α-L-aspartyl-L-phenylalanine or a derivative thereof, which comprises migrating as a primary phosphonium salt to an organic solvent phase.
【請求項2】N−保護−L−アスパラギン酸またはその
誘導体とL−フェニルアラニンまたはその誘導体とを水
中で蛋白分解酵素を用いて反応させ、生成したN−保護
−α−L−アスパルチル−L−フェニルアラニンまたは
その誘導体を4級アンモニウム塩または4級ホスホニウ
ム塩を溶解した水非混和性有機溶媒で抽出回収すること
を特徴とするN−保護−α−L−アスパルチル−L−フ
ェニルアラニンまたはその誘導体の酵素的合成法。
2. N-protected-α-L-aspartyl-L-produced by reacting N-protected-L-aspartic acid or its derivative with L-phenylalanine or its derivative in water using a protease. An enzyme of N-protected-α-L-aspartyl-L-phenylalanine or a derivative thereof, which comprises extracting and recovering phenylalanine or a derivative thereof with a water-immiscible organic solvent in which a quaternary ammonium salt or a quaternary phosphonium salt is dissolved. Synthetic method.
JP10431986A 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides Expired - Lifetime JPH0634745B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10431986A JPH0634745B2 (en) 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10431986A JPH0634745B2 (en) 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides

Publications (2)

Publication Number Publication Date
JPS62259597A JPS62259597A (en) 1987-11-11
JPH0634745B2 true JPH0634745B2 (en) 1994-05-11

Family

ID=14377613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10431986A Expired - Lifetime JPH0634745B2 (en) 1986-05-07 1986-05-07 Enzymatic synthesis of N-protected peptides

Country Status (1)

Country Link
JP (1) JPH0634745B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW306932B (en) * 1993-08-27 1997-06-01 Holland Sweetener Co
US5502165A (en) * 1994-04-04 1996-03-26 Merck & Co., Inc. Process for peptide segment condensation
US5837483A (en) * 1996-10-15 1998-11-17 Holland Sweetener Company V.O.F. Enzymatic method for producing N-formyl-α-L-aspartyl-L-phenylalanine methyl ester

Also Published As

Publication number Publication date
JPS62259597A (en) 1987-11-11

Similar Documents

Publication Publication Date Title
JPH11508452A (en) Novel method for producing peptides and N-carbamoyl protected peptides
EP0149594A2 (en) Enzymatic coupling of n-formyl amino acids and/or peptide residues
So et al. Protease-catalyzed tripeptide (RGD) synthesis
Kimura et al. Enzymatic synthesis of the precursor of Leu-enkephalin in water-immiscible organic solvent systems
US4680403A (en) Process for producing N-protected-α-L-aspartyl-L-phenylalanine methyl ester
EP0466963B1 (en) A process for the preparation of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride by use of isolated N-formyl-aspartic anhydride
JPH0634745B2 (en) Enzymatic synthesis of N-protected peptides
US6617127B2 (en) Synthesis and recovery of aspartame involving enzymatic deformylation step
US5693485A (en) Enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester
US4426325A (en) Process for the preparation of compounds containing carboxylic acid amide groups, in particular or peptides
US4892820A (en) Solvent system for enzymatic coupling process
WO2000037486A1 (en) Synthesis and recovery of aspartame involving enzymatic deformylation step
EP0768384B1 (en) Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester
US20040137559A1 (en) Process for producing N-formylamino acid and use thereof
EP0986575B1 (en) Method for preparing salts of aspartame from n-protected aspartame
Meng et al. Application of enzymes for the synthesis of the Cholecystokinin Pentapeptide (CCK-5)
EP1140982B1 (en) Synthesis and recovery of aspartame involving enzymatic deformylation step
JPH0647600B2 (en) Method for converting β-aspartylphenylalanine derivative into α-aspartylphenylalanine derivative
JP2508803B2 (en) Process for producing α-L-aspartyl-L-phenylalanine derivative
JPH10174597A (en) Enzymatic synthesis of N-formyl-α-L-aspartyl-L-phenylalanine methyl ester
JPH05284991A (en) Production of methyl ester of n-benzyloxycarbonyl-alfa-l-aspartyl-l-phenylalanine
JPH0525480B2 (en)
JPH06237784A (en) Method for synthesizing oligopeptide
JP2009512427A (en) Enzymatic conversion of oligopeptide amides to oligopeptide alkyl esters
JPH0530439B2 (en)